SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is under heavy selling pressure after its quarterly report missed estimates and full-year guidance was lowered, with management citing a promotional athletic footwear/apparel market and Foot Locker weakness. The Stocktwits crowd is split between dip buyers calling the sell-off overdone and bears expecting more downside, while broader concerns about consumer spending, tariffs, and the Foot Locker acquisition dominate the discussion.

CF Acquisition Corp. VI operates as a blank check company. It focuses on the search of companies in the financial services, healthcare, real estate services, technology and software industries. The company was founded on April 17, 2020 and is headquartered in New York, NY.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is surging after announcing a $13.7B, six-year GPU services deal with an unnamed U.S. cloud customer, with retail traders speculating on the buyer's identity and debating the financing/dilution risks while celebrating a potential short squeeze.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp is attracting significant attention as investors react to the company's progress in Greenland and the potential impact of U.S. government efforts to secure domestic supply chains for critical minerals. Community discussions are heavily focused on the company's valuation discrepancies, the Tanbreez project's long-term strategic importance, and anticipation surrounding upcoming mergers and operational milestones.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is surging as Tom Lee's comments about BitMine's ETH holdings and staking revenue covering obligations fuel a crypto-treasury rally, with retail sentiment turning extremely bullish amid hopes for a NAV premium expansion.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is surging with heavy volume after breaking above the psychologically key $0.005 level, igniting a fierce battle between bulls celebrating a potential trend reversal and bears calling it a 'dead cat bounce.' Community chatter is split between speculative JPYD stablecoin integration on JasmyChain as a fundamental catalyst and accusations of manipulation, while the noise around trending status itself has become a meme.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is seeing intense trading volume and community buzz as investors anticipate upcoming earnings and potential US market expansion news. Discussions are heavily focused on the stock's role as a proxy for the Hyperliquid exchange, with many traders debating short squeeze potential and institutional positioning.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences remains a focal point for retail investors as the market anticipates a definitive Phase 3 trial readout for its lead acute myeloid leukemia treatment. Traders are closely monitoring the stock's ability to maintain position near key resistance levels, with high short interest and institutional activity fueling intense community debate over trial timelines and potential acquisition prospects.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is under heavy fire after reporting sharply higher revenue and above-consensus 2027 guidance, yet the market is fixated on widened losses and the CFO's cautious terms for future projects, fueling a bitter bull-vs-bear debate over whether the selloff is an overreaction or a warning sign. Bulls tout the revenue ramp, improving Q2 operating performance, and hidden AI upside from unannounced wins, while bears hammer the eroding gross margins, stock-based comp, and dilution fears.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is rallying as traders and long-term holders pile in ahead of the pivotal NXC-201 topline readout for AL amyloidosis, with the community highlighting a near-perfect complete response rate, zero relapses, and a heavily shorted, tightly held float that could fuel a squeeze. The broader biotech optimism around CAR-T and a shifting FDA stance on single-arm trials is amplifying the momentum.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

Traders are focused on the relentless XBI biotech surge, amplified by Modernas sharp rally, which is crushing this leveraged inverse ETF and fueling debate over whether to average down or wait for a biotech pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info